CRISPR, base and prime editing: clinical trial readouts, regulatory decisions and the research that moves the field.
CRISPR, base and prime editing: clinical trial readouts, regulatory decisions and the research that moves the field.
On the 1st of every month at 09:00, send me an issue of up to 15 items with Gene editing, plus at least one of CRISPR, Base editing, Prime editing, Clinical trial results or Regulatory approval. Skip opinion pieces. Keep but flag press releases without data. Search the open web, starting with q-bio, and also https://www.statnews.com/feed/ and https://www.genengnews.com/feed/. Matching is balanced. Anyone can find and subscribe to it in Discover.
Streams that already watch this field. Follow one as it is — it costs nothing extra.
Real progress on the six open Millennium Prize Problems — the Riemann hypothesis, P vs NP, Navier–Stokes, Yang–Mills, Hodge and Birch–Swinnerton-Dyer: serious papers, partial results, AI-assisted advances, and what experts say about claimed solutions.
Where the P vs NP question stands: circuit and proof-complexity lower bounds, barriers, meta-complexity, geometric complexity theory, new reductions and hardness results, and how the community reads each claimed proof.
A regular roundup of the latest science news explained in plain language for readers without a science background.